This study was designed to assess the changes in nonlinear properties of heart rate (HR) variability (HRV) during the menstrual cycle by means of complexity measures, including sample entropy (SampEn) and correlation dimension (CD), and explore probable physiological interpretations for them. In 16 healthy women (mean age: 23.8 Ϯ 2.7 yr), complexity measures along with the spectral components of HRV (sympathovagal markers) were analyzed over 1,500 R-R intervals recorded during both the follicular phase (day 11.9 Ϯ 1.4) and the luteal phase (day 22.0 Ϯ 1.4) of each woman's menstrual cycle. Simultaneously, serum ovarian hormone (estradiol-17 and progesterone) and thyroid-related hormone [free triiodothyronine, free thyroxine (T4), and thyroid-stimulating hormone] concentrations were measured. With regard to HRV measures, SampEn, CD, and highfrequency (HF) components decreased from the follicular phase to the luteal phase, whereas normalized low-frequency (LF) components and the LF-to-HF ratio as well as resting HR increased. In regard to hormone levels, whereas progesterone was increased, the other hormone concentrations were unchanged. Furthermore, across the menstrual cycle, both SampEn and CD were well correlated with the spectral indexes and free T 4 concentrations, and SampEn also showed significant correlations with the ratio of estradiol-17 to progesterone concentrations. These results suggest that the nonlinear properties in HRV are altered during the regular menstrual cycle and that the autonomic nervous system, ovarian hormone balance, and free T 4 may be involved in nonlinear HR control in healthy women. All of these factors may enrich the physiological meanings of complexity measures. autonomic nervous system; ovarian hormones; thyroid hormones; complexity measures HEART RATE (HR) variability (HRV) refers to the periodic and nonperiodic variations in beat intervals or, correspondingly, in the instantaneous HR (52, 69). Because of the observation that HR fluctuation is related to various cardiovascular disorders, analyzing HRV has become a widely used tool for assessing the regulation of HR behavior (62). Traditional HRV analysis methods based on the assumptions of linear models are suitable for periodic components in HR behavior and have made progress in noninvasively detecting the state of cardiac autonomic control (34, 62, 70) . In particular, the high-frequency (HF) band (0.15-0.4 Hz) in frequency-domain analysis has been regarded as the marker of vagal activity, and the lowfrequency (LF) band (0.04 -0.15 Hz) has been regarded as the marker of sympathovagal interaction, especially sympathetic activity (3, 52, 62) . Consequently, the LF-to-HF (LF/HF) ratio represents the sympathovagal balance (62). However, the findings that the largest proportion of HRV is irregular and nonperiodic and that the nature of the cardiac control network is nonlinear (68) challenge conventional linear analysis methods and promote the development of a nonlinear HRV analysis. The nonlinear methods differ from the linear measures in that they do not attempt to assess the magnitude of HRV but instead describe the complexity or fractal dynamics of R-R intervals (27). Undoubtedly, nonlinear analysis methods may provide a different picture of HR behavior and more valuable information regarding cardiovascular regulation that is not obtainable with conventional linear methods. Among numerous nonlinear indexes, sample entropy (SampEn) (54) and correlation dimension (CD) (47) are commonly used to uncover complexity in HR dynamics. Nevertheless, their physiological meanings have not been fully elucidated. However, previous findings showing that the use of autonomic blockade agents or heart denervation can drastically reduce the complexity in HR dynamics have suggested that these nonlinear indexes may be potential tools for assessing autonomic nervous activity (24, 33, 48, 68) .
HEART RATE (HR) variability (HRV) refers to the periodic and nonperiodic variations in beat intervals or, correspondingly, in the instantaneous HR (52, 69) . Because of the observation that HR fluctuation is related to various cardiovascular disorders, analyzing HRV has become a widely used tool for assessing the regulation of HR behavior (62) . Traditional HRV analysis methods based on the assumptions of linear models are suitable for periodic components in HR behavior and have made progress in noninvasively detecting the state of cardiac autonomic control (34, 62, 70) . In particular, the high-frequency (HF) band (0.15-0.4 Hz) in frequency-domain analysis has been regarded as the marker of vagal activity, and the lowfrequency (LF) band (0.04 -0.15 Hz) has been regarded as the marker of sympathovagal interaction, especially sympathetic activity (3, 52, 62) . Consequently, the LF-to-HF (LF/HF) ratio represents the sympathovagal balance (62) . However, the findings that the largest proportion of HRV is irregular and nonperiodic and that the nature of the cardiac control network is nonlinear (68) challenge conventional linear analysis methods and promote the development of a nonlinear HRV analysis. The nonlinear methods differ from the linear measures in that they do not attempt to assess the magnitude of HRV but instead describe the complexity or fractal dynamics of R-R intervals (27) . Undoubtedly, nonlinear analysis methods may provide a different picture of HR behavior and more valuable information regarding cardiovascular regulation that is not obtainable with conventional linear methods. Among numerous nonlinear indexes, sample entropy (SampEn) (54) and correlation dimension (CD) (47) are commonly used to uncover complexity in HR dynamics. Nevertheless, their physiological meanings have not been fully elucidated. However, previous findings showing that the use of autonomic blockade agents or heart denervation can drastically reduce the complexity in HR dynamics have suggested that these nonlinear indexes may be potential tools for assessing autonomic nervous activity (24, 33, 48, 68) .
The menstrual cycle, characterized by sex hormone fluctuations, is a basic physiological factor that continuously affects body function in premenopausal women. The extent to which HRV is influenced by the menstrual cycle has been a subject of interest. For linear characteristics in HRV, inconsistent results have been reported. Most investigators (23, 57, 58, 72) have found increased LF components accompanied or unaccompanied by decreased HF components in HRV in the luteal phase compared with the follicular phase and concluded a predominant sympathetic activity in the luteal phase and a dominant vagal activity in the follicular phase. They then further attributed the findings to the cyclic variation of ovarian hormone levels during the menstrual cycle. However, Leicht et al. (38) found similar spectral properties in HRV regardless of the menstrual cycle phase and a dramatic rise and fall in endogenous female sex hormone levels. Recently, Vellejo et al. (65) pointed out that the menstrual cycle was the least important factor affecting HRV relative to age and body mass index. Moreover, Princi et al. (51) found diametrically opposite results that suggested increased parasympathetic activity and decreased sympathetic activity in the luteal phase compared with the follicular phase. Despite differences in the timing of HRV recordings, we wondered whether these confusing results may be due to the nonlinear characteristics in HRV and nonlinear HR control. To our knowledge, there is little information available in the literature about the influence of the menstrual cycle on nonlinear HRV properties (51) .
Thus, this study was designed to assess the changes in nonlinear features of HRV caused by the menstrual cycle using the complexity measures SampEn and CD. The main purpose was to explore the probable mechanisms behind these changes and gain insight into the physiological interpretations for the complexity measures of HRV.
Because it is impossible to separate nonlinear HR dynamics from the autonomic nervous control context (27, 68) , with regard to the probable mechanisms underlying menstrual cycle-related alterations in the nonlinear properties of HRV, we proposed three hypotheses. First, we hypothesized that the nonlinear property changes in HRV during the menstrual cycle would be related to cardiac autonomic control. Second, we hypothesized that cyclic variation of the ovarian hormone levels would contribute to these changes because a previous study (73) correlated ovarian hormones with sympathovagal tone. Third, we hypothesized that thyroid-related hormones may play a role in these changes because it has been observed that menstrual cycle-related alterations took place in some thyroid-associated parameters, including some thyroid-related hormone levels (5, 22, 53) , and that excessive or insufficient thyroid hormones are relevant to autonomic nervous systemmediated symptoms.
MATERIALS AND METHODS
Subjects and study protocol. Sixteen healthy female college students with a mean Ϯ SD age of 23.8 Ϯ 2.7 yr and body mass index of 20.8 Ϯ 1.2 kg/m 2 volunteered for this study. A detailed medical history was obtained from all participants, and they underwent a standard physiological examination. To avoid the probable influence of potential thyroid diseases on this research, thyroid ultrasound was performed on all subjects. All subjects were confirmed to have no heart disease, goiter, or any abnormalities on thyroid ultrasound. They were normotensive, nondiabetic, and nonsmokers, and they had no primary dysmenorrhea. None of them had taken any regular medication, including oral contraceptives, and they abstained from caffeinecontaining beverages and alcohol during the study. Their menstrual cycles, including ovulation, which was monitored by a urinary ovulation predictor (WH Ovultell, WHPM, El Monte, CA) for 3 mo before HRV determination, were regular and ranged from 27 to 32 days (mean: 29.6 days). Subjects had not exercised regularly for at least 2 mo before they entered this study. All subjects were familiar with the experimental processes and gave their written informed consent before participation. All procedures were approved by the Ethical Committee of the Fourth Hospital of Harbin Medical University and followed the ethical Declaration of Helsinki.
All female subjects were studied at each of the following phases during a single menstrual cycle: the follicular phase (day 11.9 Ϯ 1.4, range: days 10 -14) and the luteal phase (day 22.0 Ϯ 1.4, range: days 20 -24) . Both phases were further determined by color ultrasound (ESAOTE, Technos MPX DU8) according to recognizing the dominant follicle and the corpus luteum, respectively, in addition to a urinary ovulation predictor. To avoid potential diurnal variations, subjects were always tested at the same time of day (between 6:00 and 8:00 AM) in the same quiet, temperature-controlled room (21-24°C) after an overnight fast and at least 24 -36 h postexercise. All subjects were asked to be in the supine position with a spontaneous breathing rate and depth with their eyes closed and in a relaxed state at least 15 min before data collection.
HRV measurements. R-R intervals were measured for at least 30 min using a wristwatch-style monitor that recorded the output from electrodes (Suunto t6 wristop computer, Suunto Oy, Vantaa, Finland) on the chest wall with a sampling frequency of 1,000 Hz. A continuous surface ECG was also monitored (ECG machine, Schiller AT-102) to confirm the sinus origin of the beats.
R-R interval data were then transferred to a computer with the Suunto Training Manager program (Suunto Oy) and were saved as a column vector in ASCII format. Occasionally, on every record, noise (appearing as pairs of short intervals due to a false trigger that resulted from the movement of the subjects) was removed, and a small number of too-long R-R intervals at the onset of the record were also removed (11) . Finally, the remaining R-R intervals, containing 1,500 values, were stored on a computer for later HRV analysis.
Blood samples. After the HR recording, a 5-ml blood sample was collected and centrifuged to obtain serum. Serum ovarian hormones (including estradiol-17 and progesterone) and thyroid-related hormones [including free triiodothyronine (T 3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH)] were measured by an electrochemiluminescence technique using a Roche Elecsys 2010 immunoassay analyzer (Roche Diagnostics, Indianapolis, IN).
Frequency-domain analysis. This analysis was performed using HRV analysis software (version 1.1, Biomedical Signal Analysis Group, Department of Applied Physics, University of Kuopio, Kuopio, Finland; software is available from http://venda.uku.fi/research/ biosignal). Irregular R-R intervals were subjected to a cubic spline interpolation at a 2-Hz resampling rate before spectrum estimation. A Welch's periodogram was employed to assess the 1,024-point spectra with a Hanning window overlap of 512 points. The fast Fourier transform (FFT) spectra were squared to obtain the power spectra, from which two frequency bands [a LF band (0.04 -0.15 Hz) and a HF band (0.15-0.4 Hz)] as well as the total power (TP; 0.00 -0.4Hz) were defined. Each component was expressed in absolute units (in ms 2 ); meanwhile, the ratio of LF and HF was also determined. For LF and HF bands, their power was also represented in normalized units. All of the steps above were executed in accordance with the software manual (45) . In addition, by means of this software, the resting HR was also measured.
SampEn. SampEn is a "regularity statistic." It "looks for patterns" in a time series and quantifies their degree of predictability or regularity. Larger SampEn values indicate greater independence, less predictability, and hence greater complexity in the data, whereas lower values imply greater regularity in the time series (54) . SampEn is virtually a variant of approximate entropy (ApEn) (54) . We used SampEn instead of ApEn for the analysis of R-R interval time series because of its improved algorithm, i.e., SampEn excludes selfmatches in the definition of ApEn and does not use a templatewise strategy for calculating conditional probabilities (54) . These improvements of algorithm make SampEn largely independent of record length and display relative consistency under circumstances where ApEn does not (54) . Thus, SampEn reduces the bias of ApEn and has closer agreement with therory (36) . According to the algorithm described by Richman and Moorman (54) , the SampEn calculation has three parameters (N, m, and r). For every time series, the number of R-R intervals (N) in this study was 1,500. Based on previous suggestions (28), the length of sequences to be compared (m) was set to 2, and the tolerance level for determining a significant difference between R-R intervals (r) was set to 20% of the SD of the data set. Here, SampEn was computed by means of Matlab tools (http:// www.physionet.org/physiotools/sampen/matlab/).
CD. CD is one of the characteristic invariants of nonlinear system dynamics. It gives a measure of complexity for the underlying attractor of the system. To estimate the CD, the software designed for nonlinear data analysis (TSTOOL version 1.11, Universitat Gottingen, available from http://www.physic3.gwdg.de/tstool) was used according to the following methods.
At the beginning, we used a time-delay embedding method to realize the phase space trajectory reconstruction (67) , which can be implemented in four steps. An example was used to demonstrate the procedure briefly. First, the R-R interval time series derived from a normal subject was imported into the program, as shown in Fig. 1A . Second, because both proper time delay () and a minimum embedding dimension (d) are necessary for good reconstruction, we used an auto mutual information method (56) to estimate , as shown in Fig.  1B ; the value of at the first local minimum was 2. Third, we estimated d by Cao's method (12) using a of 2, a maximal dimension of 15, 3 nearest neighbors, and 1,500 reference points, as shown in Fig. 1C ; the value of d was 10. Finally, using and d, the phase-space trajectory was reconstructed. Unfortunately, because the R-R interval time series is a high-dimensional signal, the plot of phase space cannot be shown by TSTOOL successfully. After the work above, we computed the CD using Taken's estimator, as provided by TSTOOL.
Surrogate data test. The surrogate data test was performed to distinguish nonlinear HR dynamics from the linear stochastic procedure. Its basic idea is to compute a nonlinear statistic from the original data as well as from an ensemble of surrogate data (63) . The surrogate data share the same linear properties (mean, variance, and, in particular, power spectrum and coherence) as the original data but are otherwise random. These shared properties permit testing of the null hypothesis that the original data are the consequence of the linear stochastic procedure (60) . This hypothesis is tested by estimating the value of ϭ (m surr Ϫ xexp)/SDsurr (35) , where is, xexp is the nonlinear index value for the original experimental data, and msurr and SDsurr are the mean and SD of the same nonlinear parameter value for the surrogate data, respectively. A value of Ͼ 2 allows one to reject the null hypothesis and confirm the nonlinear structure of the original data (35) , where is the statistical significance of difference in the nonlinear statistics between the original and the surrogate data. Here, 10 phase-randomized surrogate data sets for each raw HRV time series were generated from TSTOOL, and SampEn and CD analyses were repeated on them.
Statistical analysis. Statistical analysis was performed with the statistical package SPSS (SPSS, Chicago, IL). Values are expressed as means Ϯ SD. All data were tested for Gaussian distribution using the Shapiro-Wilk test. To correct for skewed distributions, natural logarithmic transformation was performed on the frequency-domain indexes: HF (in ms 2 ), LF (in ms 2 ), TP (in ms 2 ), and the estradiol-17-to-progesterone (E/P) ratio.
Differences between the follicular phase and luteal phase for all experimental parameters, including HRV indexes and serum hormonal concentrations, were determined by the Student's paired t-test or the nonparametric Wilcoxon signed-rank test.
Correlations between different HRV indexes, between serum ovarian hormone levels and HRV indexes, and between serum thyroidrelated hormone levels and HRV indexes were determined by Pearson's correlation coefficient. P Ͻ 0.05 was taken as statistically significant.
RESULTS
The surrogate data test revealed that the mean values of SampEn and CD were 14.27 and 2.61, respectively. Thus, the null hypothesis, that the original HR fluctuations were derived from the linear stochastic process, was rejected because the mean was Ͼ2.
Hormone assays. Serum ovarian hormone levels (estradiol-17 and progesterone) and thyroid-related hormone levels (free T 3 , free T 4 , and TSH) during both the follicular and luteal phases of the menstrual cycle are shown in Table 1 . The serum progesterone level was significantly higher in the luteal phase than in the follicular phase (9.54 Ϯ 7.18 vs. 0.62 Ϯ 0.22, P Ͻ 0. 001), whereas the serum estradiol-17 level in the follicular phase did not significantly differ from that in the luteal phase; consequently, the E/P ratio was higher in the follicular phase compared with the luteal phase (after natural logarithmic transformation, 5.30 Ϯ 0.86 vs. 3.02 Ϯ 0.76, respectively, P Ͻ 0. 001). There were no significant menstrual cycle phase-related differences in the concentrations of any serum thyroid-related hormones.
Effects of menstrual cycle on HRV indexes, including spectral measures and complexity measures. A menstrual cyclerelated difference existed in all standard frequency-domain indexes in different units and nonlinear indexes except for LF Values are means Ϯ SD; n ϭ 16 women. E/P ratio, the ratio between serum levels of estradiol-17 and progesterone. power and TP in absolute units (Fig. 2) . LF (in normalized units) and the LF/HF ratio were significantly higher, and HF (in normalized units and ms
2 ) was significantly lower in the luteal phase than in the follicular phase (P Ͻ 0. 05 for all). Simultaneously, the complexity measures of SampEn and CD were significantly higher in the follicular phase, in contrast with those in the luteal phase (P Ͻ 0. 05 for all). In addition, a significantly greater resting HR appeared in the luteal phase rather than in the follicular phase (64.68 Ϯ 6.98 vs. 61.52 Ϯ 7.03, respectively, P ϭ 0.012).
Correlations among different HRV indexes. Table 2 shows Pearson's correlation coefficients between the different HRV measures across the whole menstrual cycle. SampEn had a notably positive correlation with HF (in ms 2 and normalized units, r ϭ 0.55 and 0.45, respectively, P Ͻ 0. 05) and TP (in ms 2 , r ϭ 0.41, P Ͻ 0. 05) and had significantly inverse correlations with LF (in normalized units, r ϭ Ϫ0.45, P Ͻ 0. 05) and the LF/HF ratio (r ϭ Ϫ0.50, P Ͻ 0. 01), whereas the CD was correlated with both HF and TP in absolute units (r ϭ 0.59 and 0.40, respectively, P Ͻ 0. 05).
Correlation between reproductive hormones and different HRV indexes. A significant correlation was demonstrated between the E/P ratio and SampEn (r ϭ 0.64, P Ͻ 0.001; Fig. 3A) . When we analyzed the follicular phase and luteal phase separately, this correlation also emerged [in the follicular phase, r ϭ 0.49, P ϭ 0.057 (Fig. 3B) ; and in the luteal phase, r ϭ0.57, P Ͻ 0. 05 (Fig. 3C) ]. In addition, neither the estradiol-17 level nor the progesterone level showed correlations with other indexes of HRV as determined by any method.
Correlation between thyroid hormones and different HRV indexes. Complexity measures of HRV (SampEn and CD) were positively correlated with the serum free T 4 level (r ϭ 0.55 and 0.56, P Ͻ 0. 01, respectively; Fig. 4, A and B) . These correlations also existed during each phase [during the follicular phase, for SampEn and CD, r ϭ 0.55 and 0.60, respectively (Fig. 4, C and D) ; and during the luteal phase, for SampEn and CD, r ϭ 0.70 and 0.57, respectively (Fig. 4 , E and F), P Ͻ 0. 05 for all]. Beyond that, other HRV indexes showed no correlations with any thyroid-related hormone levels tested.
DISCUSSION
In this study, we yielded a new finding: nonlinear properties, especially complexity in HRV as assessed by SampEn and CD, varied during the normal menstrual cycle in young women. The complexity measure variations were in synch with the changes in standard frequency domain indexes and the E/P ratio. Thus, the menstrual cycle-related variation in HRV complexity may be partially explained by the alterations in autonomic tone and the balance between serum estradiol-17 and progesterone levels. In addition, we reported the first significant correlation between complexity measures of HRV (SampEn and CD) and free T 4 concentrations in young women. Therefore, free T 4 may take part in modulating nonlinear HR dynamics.
Influence of the menstrual cycle on HR dynamics. Considering the previous controversial results of the influence of menstrual cycle on the spectral properties in HRV (23, 38, 51, 57, 58, 72), we also used standard frequency-domain indexes to investigate the alterations in the linear properties of HRV during the menstrual cycle. In agreement with previous studies (23, 58, 72), we also found dominant HF components during the follicular phase and dominant LF components and the LF/HF ratio in the luteal phase. According to the clear physiological meaning of these indexes (62), our results suggest that the follicular phase was characterized by enhanced vagal activity and that the luteal phase was characterized by enhanced sympathetic activity. This view was also strengthened by our findings and previous investigator's findings on resting HR (4), another linear indicator for assessing sympathetic activity (46) . But even so, the linear components make up only a small section of HRV, and the nature of HR control is nonlinear (68); thus, the influence of the menstrual cycle on the nonlinear properties of HRV and the mechanisms that underlie this influence were the issues of particular concern. In this study, Fig. 2 . Comparison of different heart rate variability (HRV) indexes including the standard frequency-domain indexes in both absolute units (in ms 2 ) and normalized units (NUs) (A and B) and the complexity measures (C) between the follicular phase and luteal phase. HF, high frequency; LF, low frequency; TP, total power; LF/HF, the ratio between LF and HF; SampEn, sample entropy; CD, correlation dimension. Values are means Ϯ SD. *P Ͻ 0.05; **P Ͻ 0.01. Except for LF (in ms 2 ) and TP (in ms 2 ), all indexes differed significantly between the two phases. the nonlinear indexes of SampEn and CD were used. We found that both of them changed during the menstrual cycle.
SampEn and CD, although both complexity measures for HR signals, differ from each other in nature. SampEn is the quantification of complexity from the point of view of information (13, 36) . It defines the regularity of the system. Small SampEn values are associated with pattern regularity within a signal, and larger SampEn values are associated with greater complexity (54) . CD is the quantification of dimensional complexity based on phase-space techniques and is one of the most widely used measures of fractal dimension (42) . It defines the phase-filling propensity of the R-R interval time series (37) . The bigger the CD is, the more complex the system is. Thus, either from the regularity or dimension of the system, our results indicated that more complex HR dynamics characterized the follicular phase, in contrast with the luteal phase. However, this variation in complexity of HRV during the menstrual cycle could not be detected by Princi et al. (51) by means of fractal dimension. This discrepancy may be related to the limitation of the relatively small sample size and inherent loss of statistical power in that study (51) .
Correlations between nonlinear and linear HRV measures. Our study demonstrated that a higher vagal-related index (HF) and higher complexity measures (SampEn and CD) coexisted during the follicular phase compared with the luteal phase, which suggests that higher complexity in HRV may be related to higher vagal activity, and vice versa. This view was reinforced by the significant correlations between HF and complexity measures (SampEn and CD) observed in this study and in a previous study (35) . Of course, the moderate links between complexity measures and the global marker of vagal modulation (TP) observed in this study may also contribute to this view, although the TP only declined from the follicular phase to the luteal phase but not enough to yield statistical significance (P ϭ 0.100; Fig. 2A ). Moreover, this view was further supported by direct evidence. In animal models, either cholinergic blockade (atropine) or vagatomy significantly reduced cardiovascular complexity (7, 26, 48, 74) . This reduction is similar in humans, where parasympathetic blockade with glycopyrrolate or high-dose atropine reduced heart complexity (47, 49) . In addition, in agreement with Lewis et al. (39) , we also observed that SampEn was negatively correlated with normalized LF and the LF/HF ratio, which implies that both sympathetic and vagal activities may contribute to SampEn. Thus, alterations of autonomic activities, especially parasympathetic activity, during the menstrual cycle could be partly responsible for the changes of HRV complexity. To a certain extent, our study reconfirmed the potential value of these nonlinear indexes (SampEn and CD) in assessing autonomic nervous outflow to the heart (68) .
Correlations between ovarian hormones and HR dynamics. Over the recent years, it has been speculated that menstrual cycle-related differences in the spectral properties of HRV may be a result of cyclic variation of ovarian hormone levels (57, 58, 72) . Namely, during the follicular phase, higher HF (vagal activity) may be related to higher estrogen levels, whereas higher LF and the LF/HF ratio (sympathetic activity) may be related to higher progesterone levels during the luteal phase. However, the relationship between endogenous ovarian hormone concentrations and HRV indexes had not been investigated until 2003, when Leicht et al. (38) examined HRV at times of low and high ovarian hormone levels during the menstrual cycle; they failed to find any evidence that normal cyclic variations in endogenous ovarian hormone concentrations during the menstrual cycle were significantly associated with changes in autonomic nervous activity as measured by HRV spectral analysis. This lack of association was the case in our study. Even so, the possibility that cyclic variation of endogenous ovarian hormone levels contributes to the changes of HRV during the menstrual cycle could not be excluded because previous studies have never dealt with whether there would be a relationship between endogenous ovarian hormone levels and nonlinear HRV properties. After all, HRV consists largely of nonlinear components (68) . Our study demonstrated that SampEn changed significantly in a manner that was synchronized with the balance between serum estradiol-17 and progesterone concentrations during the menstrual cycle. This synchrony suggests that the menstrual cycle-related variation in the complexity of HRV may be partially attributed to the alterations in ovarian hormone balance. The likely reason for this attribution can be explained from the effects of ovarian hormones on the autonomic nervous system. Previous studies have indicated that estrogens act as cholinergic agonists by inducing the synthesis of and activating choline acetyltransferase, the rate-limiting enzyme for acetylcholine formation (9) , and by inhibiting adrenergic outflow (17) , whereas natural progesterone at a physiological dose acts as an adrenergic agonist by inducing an increase in norepinephrine release (43) . Thus, the E/P ratio may determine the balance between parasympathetic and sympathetic activity. Coincidentally, according to the recent findings showing that SampEn values changed gradually with a progressive shift of the sympathovagal balance induced by the graded head-up tilt protocol (50) and that ApEn, SampEn's analog, can be suppressed by atropine and that this suppression can be restored by exercise (64), and our findings showing that SampEn moderately correlated with the LF/HF ratio, SampEn seems to be a global index for monitoring the sympathovagal balance. Therefore, it seems reasonable that the contribution of the ovarian hormone balance to the complexity of HRV may be mediated by the autonomic nervous system. However, the possibility that ovarian hormones directly affect the complexity of HRV could not be ruled out completely because both estrogen and progesterone receptors have been detected previously in the hearts of experimental animals (40, 61) . Additionally, in this study, the absence of a significant correlation between CD and ovarian hormone levels, including the E/P ratio, was noteworthy. We also observed a tendency for a positive correlation between CD and the E/P ratio (r ϭ 0.388, P ϭ 0.056). The loss of statistical power may be attributed to the small sample size. Therefore, the varying balance between estrogen and progesterone may alter the CD during the menstrual cycle despite the insignificant results of the correlation analysis. However, this idea needs to be further confirmed by studies with a larger number of subjects.
Correlations between thyroid-related hormones and HR dynamics. Symptoms arising from "overactivity" or "underactivity" of the thyroid gland resemble sympathovagal unbalance-mediated symptoms (32) . Serum thyroglobulin, thyroid volume, and especially thyroid-related hormone levels may vary during the menstrual cycle (5, 22, 53) . These observations resulted in our hypothesis that the influence of menstrual cycle on HRV may be related to cyclic variations of thyroid-related hormone levels. Nevertheless, in contrast to previous observations (5, 22, 53) , we failed to identify any significant difference in thyroid-related hormone levels (free T 3 , free T 4 , and TSH) between the follicular phase and luteal phase, as was reported by others (21, 29) . This finding seems to be contradictory to the evidence that suggested that menstrual cycle physiology may impact hypothalamic-pituitary-thyroid axis function (16, 21) . Some researchers (21) ascribed this contradiction to a limitation of relatively small sample size and an inherent decrease of statistical power, and this limitation also existed in our study. Moreover, another reason that also probably prevented us from identifying significant menstrual cycle-related variations in thyroid-related hormone levels is that we happened to compare thyroid-related hormone levels between the two phases under similar estrogen concentrations. It has been reported that thyroid hormone levels fluctuate in relation to circulating estrogen levels during the menstrual cycle (5, 16) and that estrogen may influence thyroid-related hormone levels via changing T 4 -binding globin levels and the sensitivity of TSH cells to negative feedback regulation of thyroid hormones (1, 2, 44, 59) . Therefore, the absence of changed thyroid-related hormone levels during the menstrual cycle in our study is not inconsistent with the concept that the menstrual cycle can influence thyroid function. This absence makes it difficult for us to accept the assumption that cyclic variations of thyroidrelated hormone levels contribute to the changes in HRV during the menstrual cycle. Interestingly, however, we found that both SampEn and CD, rather than standard frequencydomain indexes of HRV, displayed a strong positive correlation with free T 4 . This correlation suggests that free T 4 levels within a narrow physiological range may modulate the complexity of HRV, at least in young women. At present, the mechanisms underlying this modulation are unknown, but the involvement of T 4 in nonlinear HR control seems inappropriate to be explained by the classical genomic pathway of thyroid hormone action, although the nuclear thyroid hormone receptors (TRs) that mediate the genomic action widely distribute in various tissues and organs, including the nervous system and circulatory system (71) . Because in genomic action T 4 is usually thought to function as a prohormone, yielding T 3 by deiodination in peripheral tissues, T 3 , in turn, gains access to the cell interior and cell nucleus, preferentially binds to TRs, and acts as a regulator of protein synthesis, cell metabolism, and the slow business of differentiation and development (31) . In other words, the genomic action of thyroid hormone is mainly T 3 dependent. Thus, if the genomic action of thyroid hormone is the main contributor of nonlinear HR control, it should be T 3 instead of T 4 . Obviously, this deduction is inconsistent with our finding. However, we should remember, in the past more than two decades, increasing evidence has shown that the actions of thyroid hormone in a variety of cells, including those in the nervous system and heart, can also be realized independent of TRs but through membrane receptors, namely, nongenomic action (15) . In contrast to the T 3 -dependent genomic action that occurs over hours to day, the nongenomic action of thyroid hormone typically appears within minutes or even seconds and participates in alterations in solute transport and changes in the activity of signal-transducing kinases and the MAPK pathway (18, 31) . This fast, nongenomic action is just in keeping with the nature of nonlinear variations that enable the cardiovascular system to response more quickly to changing conditions. More intriguingly, this nongenomic action is often in a T 4 -dependent pathway, as evidenced by the finding that the membrane protein ␣ v ␤ 3 -integrin, identified recently as a receptor mediating nongenomic action, binds T 4 with a high affinity relative to T 3 (8, 14) . Thus, the involvement of T 4 in nonlinear HR control may be related to the nongenomic action of thyroid hormone, but this needs to be clarified by further experiments. Whether this correlation between free T 4 and nonlinear HR dynamics also applies under pathological conditions (hyperthyroidism and hypothyroidism) and in men warrants further investigations.
Practical applications. During the last two decades, a great deal of work has been devoted to discriminating the patients from the healthy population and performing risk stratification by means of nonlinear methods of HRV (10, 27, 30) . Most of these studies have suggested that nonlinear analysis methods may better reflect the abnormalities in intrinsic autonomic regulatory systems and the risk of mortality than do conventional linear HRV indexes. Nevertheless, it is difficult to recognize patients with abnormal nonlinear HRV because the nonlinear properties in HRV may be altered under some physiological conditions, and the alterations may be of a sufficient magnitude to confound the so-called alterations derived from diseases. Previous studies have pointed out many physiological factors that affect nonlinear HRV properties, including age (6), gender (35) , posture (67) , and sleep (19) , and so on. Here, we determined the influence of the menstrual cycle on the nonlinear properties of HRV. Thus, the timing of HRV measurements during the menstrual cycle must be specified when designing studies that plan to measure the cardiovascular response by means of nonlinear HRV analysis and linear HRV analysis as well, as long as they involve female subjects.
Autonomic nerve control, especially sympathetic innervations, plays an important role in the development of cardiac arrhythmias (66) . Cyclical variation in the occurrence of arrhythmias during the menstrual cycle has been noticed in premenopausal women. For instance, paroxysmal supraventricular tachycardia (55) and right ventricular outflow tract tachycardia (41) are more prevalent during the luteal phase than the follicular phase, which may be partially due to the higher sympathetic activity during the luteal phase, as was also supported by our results on both linear and nonlinear analysis of HRV. On the other hand, the higher susceptibility to arrhythmias in young women during the luteal phase may be related to the lower complexity of HRV in this phase. Some pathological states are often accompanied by reduced complexity of HR dynamics, even during their early developmental stages (30) .
Study limitations. One possible shortcoming of our study would be that we only examined HRV twice across the menstrual cycle: once during the follicular phase (day 10 -14) and once during the luteal phase (day 20 -24) . We identified the correlation between the complexity of HRV and the E/P ratio. However, this ratio is variable during the menstrual cycle. Therefore, it would be better to assess nonlinear HRV indexes in relation to the E/P ratio more frequently in the whole menstrual cycle. Second, in this study, we only considered ovarian hormones and thyroidrelated hormones as the factors that may modulate nonlinear HRV during the menstrual cycle because they may not only change their concentrations with the menstrual cycle but also may be related to autonomic nervous activity. However, there are some other humoral factors that may match the conditions mentioned above, e.g., leptin (20, 25) . They may also contribute to the alterations of nonlinear HRV properties during the menstrual cycle. Thus, these factors should be taken into account in future similar studies.
Conclusions. In conclusion, our results suggest that the menstrual cycle affects nonlinear properties, especially the complexity of HRV, in young healthy women. The observed higher complexity in HRV during the follicular phase than during the luteal phase may be ascribable to the phase-associated differences in autonomic tone and the ovarian hormone balance. This explanation was further supported by our observations that the complexity measures showed significant correlations with autonomic nervous activity-associated linear indexes and the E/P ratio. Furthermore, similar thyroid-related hormone levels in both phases suggest that the menstrual cycle-related changes in complexity of HRV may be independent of thyroid-related hormones. Nevertheless, the observed strong correlations between the complexity measures and serum free T 4 levels imply that free T 4 may play a role in nonlinear HR control. All these observations may enrich the physiological interpretations of complexity measures.
